Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
4,716,023
-
Shares change
-
-119,004
-
Total reported value, excl. options
-
$18,630,129
-
Value change
-
-$1,607,590
-
Put/Call ratio
-
64%
-
Number of buys
-
27
-
Number of sells
-
-16
-
Price
-
$3.95
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2024
61 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2024.
XBiotech Inc. - Common Shares, no par value (XBIT) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,716,023 shares
of 33,289,095 outstanding shares and own 14.17% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1,294,120 shares), VANGUARD GROUP INC (1,064,604 shares), GEODE CAPITAL MANAGEMENT, LLC (454,527 shares), MILLENNIUM MANAGEMENT LLC (263,522 shares), STATE STREET CORP (229,695 shares), NORTHERN TRUST CORP (211,476 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (144,630 shares), AMERICAN CENTURY COMPANIES INC (124,245 shares), MORGAN STANLEY (122,390 shares), and Bank of New York Mellon Corp (91,060 shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.